|
TRENDS
Retail Prescription Drug Spending In The National Health Accounts
Cynthia Smith
Recent rapid spending growth for retail drugs has largely arisen from increased use of new drugs, rather than from increasing prices of existing drugs. A sizable shift in the payment from consumers to third parties has also contributed to faster growth. Strategies such as negotiating for rebates and using tiered copayments have sought to slow spending growth but simultaneously have complicated the estimation of spending in the National Health Accounts (NHA). NHA estimates show that retail pharmaceuticals’ share of health spending is not much different than it was in 1960, although its share of gross domestic product (GDP) has tripled.
       What's this?
This article has been cited by other articles:
|
|
|
|
 
R. G. Frank, H. H. Goldman, and T. G. McGuire
Trends In Mental Health Cost Growth: An Expanded Role For Management?
Health Aff.,
May 1, 2009;
28(3):
649 - 659.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Morgan, K. Bassett, and B. Mintzes
Outcomes-Based Drug Coverage in British Columbia
Health Aff.,
May 1, 2004;
23(3):
269 - 276.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. K. Iglehart
The New Medicare Prescription-Drug Benefit -- A Pure Power Play
N. Engl. J. Med.,
February 19, 2004;
350(8):
826 - 833.
[Full Text]
[PDF]
|
|
|
|
